Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity

BMC Obesity

Volumn 1, Issue 1, 2014, Pages

  Kistorp, Caroline ^a,d   Bliddal, Henning ^b,d   Goetze, Jens P ^c   Christensen, Robin ^b   Faber, Jens ^a,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Body Composition; Hypo caloric diet; Natriuretic peptides; Obesity; Weight Loss

Indexed keywords

ADRENOMEDULLIN; PROADRENOMEDULLIN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; LOW CALORY DIET; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; RISK FACTOR; WEIGHT REDUCTION;

EID: 84986885049     PISSN: None     EISSN: 20529538     Source Type: Journal    
DOI: 10.1186/s40608-014-0024-2     Document Type: Article

References (39)

1. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS: Impact of obesity on plasma natriuretic peptide levels. Circulation 2004, 109:594-600.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
3. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P: N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005, 293:1609-1616.
4. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001, 345:1014-1021.
5. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD: Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010, 55:2062-2076.
6. Sengenes C, Zakaroff-Girard A, Moulin A, Berlan M, Bouloumie A, Lafontan M, Galitzky J: Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am J Physiol Regul Integr Comp Physiol 2002, 283:R257-R265.
7. St Peter JV, Hartley GG, Murakami MM, Apple FS: B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin Chem 2006, 52:680-685.
8. Hanusch-Enserer U, Hermann KM, Cauza E, Spak M, Mahr B, Dunky A, Rosen HR, Koller U, Prager R: Effect of gastric banding on aminoterminal pro-brain natriuretic peptide in the morbidly obese. Obes Res 2003, 11:695-698.
9. Li Y, Jiang C, Wang X, Zhang Y, Shibahara S, Takahashi K: Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues. Peptides 2007, 28:1129-1143.
10. Morgenthaler NG, Struck J, Alonso C, Bergmann A: Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 2005, 51:1823-1829.
11. Nishida H, Horio T, Suzuki Y, Iwashima Y, Kamide K, Kangawa K, Kawano Y: Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin. Peptides 2008, 29:599-605.
12. Kinoshita H, Kato K, Kuroki M, Nakamura S, Kitamura K, Hisanaga S, Fujimoto S, Eto T: Plasma adrenomedullin levels in patients with diabetes. Diabetes Care 2000, 23:253-254.
13. Lim SC, Morgenthaler NG, Subramaniam T, Wu YS, Goh SK, Sum CF: The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care 2007, 30:1513-1519.
14. Vila G, Riedl M, Maier C, Struck J, Morgenthaler NG, Handisurya A, Prager G, Ludvik B, Clodi M, Luger A: Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity (Silver Spring) 2009, 17:1184-1188.
15. Bliddal H, Leeds AR, Stigsgaard L, Astrup A, Christensen R: Weight loss as treatment for knee osteoarthritis symptoms in obese patients: 1-year results froma randomised controlled trial. Ann Rheum Dis 2011, 70:1798-1803.
16. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P: Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005, 11:S15-S20.
17. Salamone LM, Fuerst T, Visser M, Kern M, Lang T, Dockrell M, Cauley JA, Nevitt M, Tylavsky F, Lohman TG: Measurement of fat mass using DEXA: a validation study in elderly adults. J Appl Physiol 2000, 89:345-352.
18. Karl J, Borgya A, Gallusser A, Huber E, Krueger K, Rollinger W, Schenk J: Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 1999, 230:177-181.
19. Abrahamsson N, Engstrom BE, Sundbom M, Karlsson FA: Gastric bypass surgery elevates NT-ProBNP levels. Obes Surg 2013, 23(9):1421-1426.
20. Changchien EM, Ahmed S, Betti F, Higa J, Kiely K, Hernandez-Boussard T, Morton J: B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss. Surg Endosc 2011, 25:2338-2343.
21. Chen-Tournoux A, Khan AM, Baggish AL, Castro VM, Semigran MJ, McCabe EL, Moukarbel G, Reingold J, Durrani S, Lewis GD, Newton-Cheh C, Scherrer-Crosbie M, Kaplan LM, Wang TJ: Effect of weight loss after weight loss surgery on plasma N-terminal pro-B-type natriuretic peptide levels. Am J Cardiol 2010, 106:1450-1455.
22. Chainani-Wu N, Weidner G, Purnell DM, Frenda S, Merritt-Worden T, Kemp C, Kersh E, Ornish D: Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes. Am J Cardiol 2010, 105:1570-1576.
23. Minami J, Nishikimi T, Ishimitsu T, Makino Y, Kawano Y, Takishita S, Kangawa K, Matsuoka H: Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. J Cardiovasc Pharmacol 2000, 36(Suppl 2):S83-S86.
24. Bartels ED, Nielsen JM, Bisgaard LS, Goetze JP, Nielsen LB: Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology 2010, 151:5218-5225.
25. Moro C, Crampes F, Sengenes C, De Glisezinski I, Galitzky J, Thalamas C, Lafontan M, Berlan M: Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J 2004, 18:908-910.
26. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessi-Fulgheri P, Zhang C, Takahashi N, Sarzani R, Collins S: Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 2012, 122:1022-1036.
27. Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, Schwarz P, Faber J: Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status. Endocrine 2013, 43:626-634.
28. Sugisawa T, Kishimoto I, Kokubo Y, Nagumo A, Makino H, Miyamoto Y, Yoshimasa Y: Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetes. Diabetes Res Clin Pract 2010, 89:174-180.
29. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, Frohlich ED: Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004, 43:1590-1595.
30. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA: Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005, 112:2163-2168.
31. Palmer SC, Yandle TG, Nicholls MG, Frampton CM, Richards AM: Regional clearance of amino-terminal pro-brain natriuretic peptide from human plasma. Eur J Heart Fail 2009, 11:832-839.
32. Deng Y, Kaufman S: The influence of reproductive hormones on ANF release by rat atria. Life Sci 1993, 53:689-696.
33. Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, de Lemos JA: Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol 2007, 49:109-116.
34. Newman AB, Lee JS, Visser M, Goodpaster BH, Kritchevsky SB, Tylavsky FA, Nevitt M, Harris TB: Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. Am J Clin Nutr 2005, 82:872-878.
35. Chaston TB, Dixon JB, O'Brien PE: Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond) 2007, 31:743-750.
36. Heinisch BB, Vila G, Resl M, Riedl M, Dieplinger B, Mueller T, Luger A, Pacini G, Clodi M: B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men. Diabetologia 2012, 55:1400-1405.
37. Isumi Y, Shoji H, Sugo S, Tochimoto T, Yoshioka M, Kangawa K, Matsuo H, Minamino N: Regulation of adrenomedullin production in rat endothelial cells. Endocrinology 1998, 139:838-846.
38. Algahim MF, Lux TR, Leichman JG, Boyer AF, Miller CC III, Laing ST, Wilson EB, Scarborough T, Yu S, Snyder B, Wolin-Riklin C, Kyle UG, Taegtmeyer H: Progressive regression of left ventricular hypertrophy two years after bariatric surgery. Am J Med 2010, 123:549-555.
39. Pivovarova O, Gogebakan O, Kloting N, Sparwasser A, Weickert MO, Haddad I, Nikiforova VJ, Bergmann A, Kruse M, Seltmann AC, Luher M, Pfeiffer AF, Rudovich N: Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J Clin Endocrinol Metab 2012, 97:E731-E739.